FDA Drug Application (022426) for OSENI by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number022426
Product Number001
FormTABLET;ORAL
DosageEQ 25MG BASE;EQ 15MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameOSENI
Active IngredientALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient ALOGLIPTIN BENZOATE3
List of drugs with Active Ingredient PIOGLITAZONE HYDROCHLORIDE9


Back to FDA Applications sponsored by TAKEDA PHARMS USA